NRx Pharmaceuticals, Inc. (NRXP) vs Organigram Global Inc. (OGI)

A side-by-side comparison of NRx Pharmaceuticals, Inc. and Organigram Global Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — NRXP vs OGI

growth of $100 · dividends reinvested · last 7y
NRXP -97.2% (-40.1%/yr)OGI -97.0% (-39.4%/yr)OGI compounded faster over this window
0200400600Start $100202120232025$3$3
NRXP OGI

NRXP vs OGI: by the numbers

  • •OGI is the larger company ($134M vs $125M market cap).
  • •OGI is profitable (27.54% net margin) while NRXP runs a net loss (-691.81%).

Metrics side by side

Valuation

MetricNRXPOGI
P/E ratioN/A2.13
P/S ratio36.930.60
P/B ratioN/A0.39
EV / EBITDAN/A10.44

Profitability

MetricNRXPOGI
Gross margin58.78%3.67%
Operating margin-1324.41%-34.07%
Net margin-691.81%27.54%
ROEN/A15.55%
ROICN/A-0.98%

Growth (annualized)

MetricNRXPOGI
Revenue CAGR (5Y)N/A29.78%
Total return CAGR (5Y)-49.61%-36.62%

Frequently asked

Is NRXP or OGI more profitable?
OGI runs the higher net margin — NRXP at -691.81% versus OGI at 27.54%.
How have NRXP and OGI total returns compared?
Over the past 5 years, NRXP delivered -49.61% and OGI delivered -36.62% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.